HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 54 filers reported holding HARPOON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $56,000 | -34.1% | 11,200 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $85,000 | -3.4% | 11,200 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $88,000 | -52.9% | 11,200 | -17.1% | 0.00% | -66.7% |
| Q2 2021 | $187,000 | -72.0% | 13,508 | -57.7% | 0.01% | -76.0% |
| Q1 2021 | $668,000 | +32.8% | 31,937 | -6.1% | 0.02% | -43.2% |
| Q4 2019 | $503,000 | – | 34,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 3,130,267 | $43,417,000 | 8.07% |
| MPM BioImpact LLC | 3,196,707 | $44,338,000 | 7.28% |
| Aquilo Capital Management, LLC | 712,674 | $9,885,000 | 2.57% |
| Logos Global Management LP | 800,000 | $11,096,000 | 0.93% |
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $3,364,000 | 0.86% |
| VR Adviser, LLC | 512,005 | $7,102,000 | 0.86% |
| SECTORAL ASSET MANAGEMENT INC | 580,759 | $8,055,000 | 0.65% |
| Avidity Partners Management LP | 1,500,000 | $20,805,000 | 0.56% |
| Orbimed Advisors | 2,611,308 | $36,219,000 | 0.37% |
| Maven Securities LTD | 618,610 | $8,456,000 | 0.34% |